House Panel Holds Hearing on Bills to Address Opioid Crisis

Mar 21, 2018 - 02:24 PM

The House Energy and Commerce Health Subcommittee today opened a two-day hearing on 25 bills designed to address the opioid crisis. Witnesses from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration outlined steps their agencies are taking to address the epidemic. Witnesses from The Kennedy Forum, Community Anti-Drug Coalitions of America, Biotechnology Innovation Organization, Association for Accessible Medicines, and DisposeRx also testified. AHA is weighing in on the bills with the committee. Chairmen of the relevant committees in Congress have said they hope to enact comprehensive legislation by Memorial Day. The subcommittee hearing will continue tomorrow with testimony from additional witnesses. 

Related News Articles

Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
AHA sends SUPPORT Act reauthorization recommendations to House committee  
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
Agencies release guidance on buprenorphine prescribing 
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA revamps Opioid Stewardship Hub
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
FDA requires labeling updates for all opioid pain medicines 
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…